POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
2013 and Recent Corporate Highlights
In September 2013, POZEN and Sanofi US announced the…
POZEN reports total revenue of $4.7 million for fourth quarter 2013
No comments:
Post a Comment